Esketamine, the drug that has been approved by FDA in 2019, has been approved for treatment of -: (A) Depression, (B) Resistant schizophrenia, (C) Bipolar disorder, (D) Ketamine dependence
Answer is A. In 2019,FDA approved nasal spray of Esketamine It is an enantiomer of ketamine Given as a nasal spray under the practitioner's supervision. used for TRD(treatment resistant depression) Given with oral antidepressants.